Els M.A. van de Westerlo

832 total citations
20 papers, 690 citations indexed

About

Els M.A. van de Westerlo is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Els M.A. van de Westerlo has authored 20 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cell Biology and 6 papers in Hematology. Recurrent topics in Els M.A. van de Westerlo's work include Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (12 papers) and Platelet Disorders and Treatments (6 papers). Els M.A. van de Westerlo is often cited by papers focused on Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (12 papers) and Platelet Disorders and Treatments (6 papers). Els M.A. van de Westerlo collaborates with scholars based in Netherlands, United Kingdom and United States. Els M.A. van de Westerlo's co-authors include Toin H. Van Kuppevelt, Gerdy B. ten Dam, Elly M. M. Versteeg, T. H. M. S. M. Van Kuppevelt, J.H. Veerkamp, R. Maatman, Toon F.C.M. Smetsers, Goos N.P. van Muijen, Leon F.A.G. Massuger and Ulf Lindahl and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Els M.A. van de Westerlo

19 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Els M.A. van de Westerlo Netherlands 12 488 420 89 67 52 20 690
Jin-Ping Li Sweden 10 376 0.8× 389 0.9× 34 0.4× 87 1.3× 55 1.1× 15 571
Alamelu G. Bharadwaj Canada 13 530 1.1× 184 0.4× 43 0.5× 29 0.4× 62 1.2× 20 738
N Takami Japan 10 312 0.6× 114 0.3× 24 0.3× 15 0.2× 23 0.4× 13 535
Rebecca S. Dise United States 8 338 0.7× 123 0.3× 110 1.2× 6 0.1× 23 0.4× 9 600
Nicole C. Smits United States 14 252 0.5× 153 0.4× 26 0.3× 26 0.4× 41 0.8× 18 537
Norihisa Kikuchi Japan 12 360 0.7× 68 0.2× 27 0.3× 31 0.5× 48 0.9× 20 750
Arivusudar Marimuthu United States 14 606 1.2× 88 0.2× 29 0.3× 11 0.2× 13 0.3× 17 933
H Ostrowska Poland 16 419 0.9× 98 0.2× 15 0.2× 22 0.3× 59 1.1× 50 634
I Ohkubo Japan 12 292 0.6× 59 0.1× 71 0.8× 9 0.1× 77 1.5× 20 643
Jean Piero Margaria Italy 11 407 0.8× 212 0.5× 7 0.1× 19 0.3× 25 0.5× 17 641

Countries citing papers authored by Els M.A. van de Westerlo

Since Specialization
Citations

This map shows the geographic impact of Els M.A. van de Westerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els M.A. van de Westerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els M.A. van de Westerlo more than expected).

Fields of papers citing papers by Els M.A. van de Westerlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els M.A. van de Westerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els M.A. van de Westerlo. The network helps show where Els M.A. van de Westerlo may publish in the future.

Co-authorship network of co-authors of Els M.A. van de Westerlo

This figure shows the co-authorship network connecting the top 25 collaborators of Els M.A. van de Westerlo. A scholar is included among the top collaborators of Els M.A. van de Westerlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els M.A. van de Westerlo. Els M.A. van de Westerlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westerlo, Els M.A. van de, et al.. (2024). Mitochondrial Morphofunctional Profiling in Primary Human Skin Fibroblasts Using TMRM and Mitotracker Green Co-staining. Methods in molecular biology. 2878. 223–232.
2.
Dieteren, Cindy E., Jori A. Wagenaars, Els M.A. van de Westerlo, et al.. (2023). Stress‐dependent macromolecular crowding in the mitochondrial matrix. The EMBO Journal. 42(7). e108533–e108533. 16 indexed citations
3.
Westerlo, Els M.A. van de, et al.. (2020). Construction and evaluation of an antibody phage display library targeting heparan sulfate. Glycoconjugate Journal. 37(4). 445–455. 9 indexed citations
4.
Versteeg, Elly M. M., et al.. (2018). Dynamic Expression of Genes Involved in Proteoglycan/Glycosaminoglycan Metabolism during Skin Development. BioMed Research International. 2018. 1–16. 2 indexed citations
5.
Kuppevelt, Toin H. Van, et al.. (2017). Sequencing of glycosaminoglycans with potential to interrogate sequence-specific interactions. Scientific Reports. 7(1). 14785–14785. 11 indexed citations
6.
Wijk, Xander M.R. van, Arie Oosterhof, Elly M. M. Versteeg, Els M.A. van de Westerlo, & Toin H. Van Kuppevelt. (2014). ‘Immunosequencing’ of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)3 motif, recognized by antibody NS4F5, is located towards the non-reducing end. Biochemical Journal. 461(3). 461–468. 5 indexed citations
7.
Holley, Rebecca, Raymond A. Smith, Els M.A. van de Westerlo, et al.. (2014). Use of Flow Cytometry for Characterization and Fractionation of Cell Populations Based on Their Expression of Heparan Sulfate Epitopes. Methods in molecular biology. 1229. 239–251. 3 indexed citations
8.
Houben, Anna J.S., Xander M.R. van Wijk, Laurens A. van Meeteren, et al.. (2012). The Polybasic Insertion in Autotaxin α Confers Specific Binding to Heparin and Cell Surface Heparan Sulfate Proteoglycans. Journal of Biological Chemistry. 288(1). 510–519. 45 indexed citations
9.
Fernig, David G., Edwin C. Jesudason, Paul D. Losty, et al.. (2009). Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics. Journal of Biological Chemistry. 284(51). 35621–35631. 33 indexed citations
10.
Dam, Gerdy B. ten, Shuhei Yamada, Fumi Kobayashi, et al.. (2009). Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas. Histochemistry and Cell Biology. 132(1). 117–127. 28 indexed citations
11.
Dam, Gerdy B. ten, Els M.A. van de Westerlo, Anurag Purushothaman, et al.. (2007). Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor Binding. American Journal Of Pathology. 171(4). 1324–1333. 103 indexed citations
12.
Dam, Gerdy B. ten, Sindhulakshmi Kurup, Els M.A. van de Westerlo, et al.. (2005). 3-O-Sulfated Oligosaccharide Structures Are Recognized by Anti-heparan Sulfate Antibody HS4C3. Journal of Biological Chemistry. 281(8). 4654–4662. 96 indexed citations
13.
Smetsers, Toon F.C.M., Els M.A. van de Westerlo, Gerdy B. ten Dam, et al.. (2004). Human Single-Chain Antibodies Reactive with Native Chondroitin Sulfate Detect Chondroitin Sulfate Alterations in Melanoma and Psoriasis. Journal of Investigative Dermatology. 122(3). 707–716. 65 indexed citations
14.
Dam, Gerdy B. ten, Els M.A. van de Westerlo, Toon F.C.M. Smetsers, et al.. (2004). Detection of 2-O-Sulfated Iduronate and N-Acetylglucosamine Units in Heparan Sulfate by an Antibody Selected against Acharan Sulfate (IdoA2S-GlcNAc). Journal of Biological Chemistry. 279(37). 38346–38352. 20 indexed citations
15.
Smetsers, Toon F.C.M., Els M.A. van de Westerlo, Gerdy B. ten Dam, et al.. (2003). Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma.. PubMed. 63(11). 2965–70. 45 indexed citations
16.
Smits, Nicole C., et al.. (2003). Heterogeneity of Heparan Sulfates in Human Lung. American Journal of Respiratory Cell and Molecular Biology. 30(2). 166–173. 40 indexed citations
17.
Westerlo, Els M.A. van de, Toon F.C.M. Smetsers, Robert J. Linhardt, et al.. (2002). Human single chain antibodies against heparin: selection, characterization, and effect on coagulation. Blood. 99(7). 2427–2433. 44 indexed citations
18.
Westerlo, Els M.A. van de, et al.. (1996). Nucleotides regulate the binding affinity of the recombinant type A cholecystokinin receptor in CHO K1 cells. Regulatory Peptides. 61(2). 87–93. 3 indexed citations
19.
Westerlo, Els M.A. van de, et al.. (1994). Rat Pancreatic Nucleoside Diphosphate Kinase, a Novel Regulator of Cholecystokinin Receptor Affinity. Annals of the New York Academy of Sciences. 713(1). 350–352. 2 indexed citations
20.
Maatman, R., Els M.A. van de Westerlo, T. H. M. S. M. Van Kuppevelt, & J.H. Veerkamp. (1992). Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochemical Journal. 288(1). 285–290. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026